期刊文献+

以iTRAQ技术分析大鼠肝纤维化发展成肝癌过程中肝组织差异表达的蛋白质 被引量:4

Proteomic identification of differentially expressed proteins in rat hepatocarcinogenesis using iTRAQ technology
下载PDF
导出
摘要 目的:分析大鼠肝纤维化发展成为肝癌过程中肝组织差异表达的蛋白,以寻找其发展过程中的关键蛋白.方法:以二乙基亚硝胺(diethylinitrosamine,DEN)建立大鼠肝纤维化-肝癌模型,采用同位素标记相对和绝对定量(isobaric tags for relative and absolute quantitation,iT RAQ)技术结合2D-LC-MS/MS(two dimensional liquid chromatography-tandem mass spectrometry)定量蛋白质组学技术,分析和鉴定建模过程中的第4、10、12、18周肝组织蛋白质的差异表达,经生物信息学分析差异表达的蛋白质功能.结果:质谱分析共鉴定到530种蛋白质.4个时间点鉴定到的差异蛋白质数量分别为128、113、106、127个,均重复鉴定到的差异蛋白为49个,其中上调蛋白37个,下调蛋白12个.通过对这些差异蛋白进行功能分析,发现他们参与翻译后修饰、转录、重组和信号传导等过程.结论:iTRAQ结合LC-ESI-MS/MS定量蛋白质组学技术能整体、动态分析的大鼠肝纤维化演变肝癌过程中的蛋白质表达变化,其中鉴定到过氧化物还原酶1(peroxiredoxin-1,Prdx1)、过氧化物还原酶2(peroxiredoxin-2,Prdx2)、硫代硫酸硫基转移酶(thiosulfate sulfurtransferase,Tst)、真核翻译起始因子3b(eukaryotic translation initiation factor 3subunit b,e IF3b)、α2-HS-糖蛋白(alpha-2-HS-glycoprotein,Ahsg)和超氧化物歧化酶1(superoxide dismutase 1,SOD1)蛋白可能是肝纤维化发展为肝癌过程中的关键蛋白,值得进一步深入探讨研究. AIM: To identify differentially expressed proteins in rat hepatocarcinogenesis. METHODS: Sprague-Dawley rats were randomly divided into a diethylinitrosamine (DEN) group and a normal control group. The DEN group was administrated 0.01% DEN solution in water for 18 wk, and the control group was given vehicle. The animals were sacrificed at the end of the 4~, 10th, 12th, or 18th week. Liver tissue proteins were quantified and identified using the isobaric tags for relative an absolute quantitation (iTRAQ) technology with two dimensional liquid chromatography- tandem mass spectrometry (2DLC-MS/MS). The functions of differentially expressed proteins were analyzed by bioinformatics. RESULTS: A total of 530 proteins were identified by MS, and the numbers of differentially expressed proteins at the four time points were 128, 113, 106 and 127, respectively. Forty-nine proteins were identified simultaneously at two or more time points, of which 37 were up-regulated and 12 down-regulated. Bioinformatics analysis indicated that differentially expressed proteins are associated with post-translational modification, transcription, recombination and signal transduction pathways.CONCLUSION: The protein changes in the process of rat hepatocarcinogenesis can be observed dynamically by iTRAQ combined with LC-ES|-MS/MS. Six proteins (peroxiredoxin-1, peroxiredoxin-2, thiosulfate sulfurtransferase, eukaryotic translation initiation factor 3 subunit b, alpha-2-HS-glycoprotein, and superoxide dismutase 1) are associated closely with hepatic fibrosis or hepatic carcinoma, and they may play critical roles in hepatocarcinogenesis.
出处 《世界华人消化杂志》 CAS 2015年第12期1873-1882,共10页 World Chinese Journal of Digestology
基金 广西自然科学基金资助项目 No.2013GXNSFBA019167 广西区域性高发肿瘤防治研究(教育部)重点实验室基金资助项目 Nos.GK2013-13-A-01-03 GK2014-ZZ05~~
关键词 肝纤维化-肝癌模型 差异蛋白 ITRAQ Hepatocarcinogenesis Differentialprotein iTRAQ
  • 相关文献

参考文献28

  • 1Seki E, De Minicis S, Osterreicher CH, Kluwe J, Osawa Y, Brenner DA, Schwabe RF. TLR4 enhances TGF-beta signaling and hepatic fibrosis. Nat Med 2007; 13:1324-1332 [PMID: 17952090 DOI: 10.1038/nm1663].
  • 2Luedde T, Trautwein C. A molecular link between inflammation and fibrogenesis: the bacterial microflora influences hepatic fibrosis via toll-like receptor 4-dependent modification of transforming growth factor-beta signaling in hepatic stellate cells. Hepatology 2008; 47:1089-1091 [PMID: 18306215 DOI: 10.1002/hep.222321.
  • 3Naugler WE, Sakurai T, Kim S, Maeda S, Kim K, Elsharkawy AM, Karin M. Gender disparity in liver cancer due to sex differences in MyD88-dependent IL-6 production. Science 2007; 317:121-124 [PMID: 17615358 DOI: 10.1126/science.1140485].
  • 4Machida K, Tsukamoto H, Mkrtchyan H, Duan L, Dynnyk A, Liu HM, Asahina K, Govindarajan S, Ray R, Ou JH, Seki E, Deshaies R, Miyake K, Lai MM. Toll-like receptor 4 mediates synergism between alcohol and HCV in hepatic oncogenesis involving stem cell marker Nanog. Proc Natl Acad Sci U S A 2009; 106:1548-1553 [PMID: 19171902 DOI: 10.1073/pnas.0807390106].
  • 5Matsuzaki K, Murata M, Yoshida K, Sekimoto G, Uemura Y, Sakaida N, Kaibori M, Kamiyama Y, Nishizawa M, Fujisawa J, Okazaki K, Seki T. Chronic inflammation associated with hepatitis C virus infection perturbs hepatic transforming growth factor beta signaling, promoting cirrhosis and hepatocellular carcinoma. Hepatology 2007; 46: 48-57 [PMID: 17596875 DOI: 10.1002/hep.21672].
  • 6Fransvea E, Angelotti U, Antonaci S, Giannelli G. Blocking transforming growth factor-beta up-regulates E-cadherin and reduces migration and invasion of hepatocellular carcinoma cells. Hepatology 2008; 47:1557-1566 PMID: 18318443 DOI: 10.1002/hep.22201].
  • 7Coulouarn C, Factor VM, Thorgeirsson SS. Transforming growth factor-beta gene expression signature in mouse hepatocytes predicts clinical outcome in human cancer. Hepatology 2008; 47:2059-2067 [PMID: 18506891 DOI: 10,1002/ hep.22283].
  • 8Friedman SL. Mechanisms of hepatic fibrogenesis. Gastroenterology 2008; 134:1655-1669 [PMID: 18471545 DOI: 10.1053/i.astro.2008.03.0031.
  • 9李彦,李小弟,廖明.二乙基亚硝胺诱发大鼠肝纤维化-肝癌动物模型的建立[J].实验动物科学,2013,30(5):20-23. 被引量:9
  • 10赵焱,应万涛,钱小红.质谱MRM技术在蛋白质组学研究中的应用[J].生命的化学,2008,28(4):210-213. 被引量:9

二级参考文献35

共引文献23

同被引文献55

  • 1周海波,颜云,蔡建庭,杜勤,陈金明.三羟基异黄酮诱导胃癌原代细胞凋亡的分子机制[J].世界华人消化杂志,2005,13(4):504-507. 被引量:5
  • 2杨锦林,王琼,吴宗英,李献,王一平.Genistein对肝癌细胞株SMMC-7721的抑制作用及对其癌基因表达的影响[J].中华肝脏病杂志,2006,14(8):622-623. 被引量:3
  • 3George Kolios,Vassilis Valatas,Elias Kouroumalis.Role of Kupffer cells in the pathogenesis of liver disease[J].World Journal of Gastroenterology,2006,12(46):7413-7420. 被引量:76
  • 4阿依恒.曲库尔汗,阿孜古丽.吐尔逊,卢晓梅,刘立中.Genistein对人鼻咽癌细胞系CNE抑制增殖和促进凋亡的研究[J].中华耳鼻咽喉头颈外科杂志,2007,42(10):783-785. 被引量:3
  • 5Li Y, Ahmed F, Ali S, Philip PA, Kucuk O, Sarkar FH. Inactivation of nuclear factor kappaB by soy isoflavone genistein contributes to increased apoptosis induced by chemotherapeutic agents in human cancer cells. Cancer Res 2005; 65: 6934-6942.
  • 6Mohammad RM, Banerjee S, Li Y, Aboukameel A, Kucuk O, Sarkar FH. Cisplatin-induced antitumor activity is potentiated by the soy isoflavone genistein in BxPC-3 pancreatic tumor xenografts. Cancer 2006; 106: 1260-1268.
  • 7Bouchal P, Roumeliotis T, Hrstka R, Nenutil R, Vojtesek B, Garbis SD. Biomarker discovery in low-grade breast cancer using isobaric stable isotope tags and two-dimensional liquid chromatography-tandem mass spectrometry (iTRAQ-2DLC-MS/MS) based quantitative proteomic analysis. J Proteome Res 2009; 8: 362-373.
  • 8Tanabe M, Ieiri I, Nagata N, Inoue K, Ito S, Kanamori Y, Takahashi M, Kurata Y, Kigawa J, Higuchi S, Terakawa N, Otsubo K. Expression of P-glycoprotein in human placenta: relation to genetic polymorphism of the multidrug resistance (MDR)-1 gene. J Pharmacol Exp Ther 2001; 297: 1137-1143.
  • 9Banerjee S, Li Y, Wang Z, Sarkar FH. Multi-targeted therapy of cancer by genistein. Cancer Lett 2008; 269: 226-242.
  • 10Imbert-Bismut F, Ratziu V, Pieroni L, Charlotte F, Benhamou Y, Poynard T. Biochemical markers of liver fibrosis in patients with hepatitis C virus infection: a prospective study. Lancet 2001; 357: 1069-1075.

引证文献4

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部